-
Symposium on Cardiomyopathy Research and Treatment
-
LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics and its Gene Therapy Programs for Rare Cardiovascular Diseases
-
Philanthropists Give $3.25 Million to Support Heart Disease Research
-
$3.25 Million Donation Made Toward Heart Disease Research at UC San Diego
-
How Gene Therapy May Hold Key to Treating Life-Threatening Cardiac Disease
-
Artificial intelligence tool predicts life expectancy in heart failure patients
-
UCSD’s Eric Adler, James Hagood Getting $2.2M for Stem Cell Studies